James Krainson
Pulmonary Disease · Miami, FLNPI 1174519987
Payments from drug & device makers
Across 704 payments — averaging $16,608 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$10.2M
- Pfizer$784K
- AstraZeneca$153K
- Merck$149K
- Eisai Inc.$144K
- GSK$115K
- plus $161K from 10 others
Across 21 payments — averaging $4282.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$88K
- GSK$1K
- Regeneron$885
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 501 | $10,186,452 |
| Pfizer | 44 | $783,982 |
| AstraZeneca | 16 | $152,865 |
| Merck | 6 | $148,817 |
| Eisai Inc. | 10 | $144,379 |
| GSK | 25 | $114,747 |
| Cipla USA Inc. | 22 | $66,617 |
| Boehringer Ingelheim Canada Ltd.ltee | 48 | $32,695 |
| Eli Lilly | 5 | $31,768 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $20,517 |
| Boehringer Ingelheim | 7 | $7,082 |
| Chiesi USA, Inc. | 2 | $1,945 |
| Novartis | 5 | $255 |
| Resmed Corp | 1 | $37 |
| Fisher & Paykel Healthcare Inc | 1 | $35 |
| Jazz Pharmaceuticals Inc. | 2 | $16 |
How this compares
$11,692,208 in reported general payments places this provider in the 95th percentile of 953 pulmonary disease providers in Florida.
Other pulmonary disease in Miami
- Lourdes BoschMiami$4.2M
- Manuel SuarezMiami$3M
- Eduardo VasquezMiami$1.9M
- Manuel Hernandez-AbrilMiami$1.9M
- Jaime AvecillasMiami$1.6M
- Trishul SiddharthanMiami$1.2M
- Shirin ShafazandMiami$969K
- Yoel BritoMiami$802K
- Maria Tupayachi OrtizMiami$716K
- Michael HernandezMiami$573K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.